New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis

Madhukar Pai(McGill University Health Centre), Keertan Dheda(University of Cape Town)
Expert Review of Molecular Diagnostics
May 1, 2006
10.1586/14737159.6.3.413
Cited by 240

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Tuberculosis
|Nature Reviews Disease Primers|2016|1.2k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639
The Lancet Commission on diagnostics: transforming access to diagnostics
|The Lancet|2021|442